CD8A and neoplasm: In normal immune processes, CD1c+ cDCs promote Th2 and Th17 immune responses against extracellular pathogens and CD4+ T cell priming, while CD141+ cDCs induce Th1 immune responses with a role in CD8+ T cell priming against tumor cells (66).